2018 American Transplant Congress » Concurrent Session: Biomarkers, Immune Monitoring and Outcomes: Clinical
Date: Tuesday, June 5, 2018
Time: 4:30pm-6:00pm
Location: Room 602/603/604
Session Type: Concurrent Session
Meeting: 2018 American Transplant Congress
- 4:30pm-4:42pm
Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection
- 4:42pm-4:54pm
Prospective Multicenter Validation of Human Transitional B Cell Cytokines as a Predictive Biomarker in Renal Transplantation
- 5:06pm-5:18pm
A Novel Peripheral Blood mRNA Biomarker Predicts Subclinical Rejection and Kidney Transplant Outcomes
- 5:18pm-5:30pm
Unbiased Sequencing of Urine Cell-Free DNA (cfDNA) to Evaluation Urine Virome and Associated Renal Allograft Damage
« View all sessions from the 2018 American Transplant Congress